SCI Pharmtech Inc (4119)

Taiwan
Currency in TWD
85.70
+0.90(+1.06%)
Closed
4119 Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
Fair Value
Day's Range
84.7085.80
52 wk Range
82.5098.80
Key Statistics
Edit
Bid/Ask
87.00 / 87.10
Prev. Close
84.8
Open
85.2
Day's Range
84.7-85.8
52 wk Range
82.5-98.8
Volume
85.46K
Average Volume (3m)
272.91K
1-Year Change
-9.31%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4119 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth
Show more

SCI Pharmtech Company Profile

SCI Pharmtech, Inc., together with its subsidiary, engages in the research and development, manufacture, and sale of active pharmaceutical ingredients, intermediates, and specialty chemicals in Italy, the United States, Japan, Germany, Taiwan, Switzerland, China, and internationally. The company offers active pharmaceutical ingredients, including adenine, articaine HCl, atomoxetine HCl, bisoprolol hemifumarate, brinzolamide, buprenorphine and buprenorphine HCl, cannabidol, divalproex sodium, duloxetine HCl, hydroxychloroquine sulfate, loxoprofen sodium, methylphenidate HCl, pentobarbital sodium, pimobendan, probucol, propafenone HCI, sodium valproate, thiopental, and valproic acid; and develops benserazide, CBN, and CBD. It also provides intermediate products, such as diethyl isobutyl malonate, benzhydrylamine, 1-Benzhydrylazetidin-3-ol, azetidin-3-ol hydrogenchloride, 1-(2-hydroxyphenyl)-3-phenylpropan-1-one, ritalinic acid, d-ritalinic acid HCl, pyrogallol aldehyde, menthadienol, 5-pentylbenzene-1,3-diol olivetol, methyl 2,4-dihydroxy-6-pentylbenzoate, ethyl 2,4-dihydroxy-6-pentylbenzoate ethyl olivetolate, divarinol, lisdexamfetamine intermediate, UDP-GIcNAz, and UDP-GaINAz. In addition, the company offers customized production services. The company was incorporated in 1987 and is based in Taoyuan City, Taiwan.

Employees
239
Market
Taiwan

Compare 4119 to Peers and Sector

Metrics to compare
4119
Peers
Sector
Relationship
P/E Ratio
21.2x0.0x−0.6x
PEG Ratio
1.280.000.00
Price/Book
1.9x0.0x2.6x
Price / LTM Sales
7.2x0.0x3.1x
Upside (Analyst Target)
-0.0%51.3%
Fair Value Upside
Unlock0.0%7.3%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 4.09
Dividend Yield
1.46%
Industry Median 1.03%
Annualised payout
1.2500
Paid annually
5-Years Growth
-16.67%
Growth Streak

Earnings

Latest Release
Nov 08, 2024
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the SCI Pharmtech (4119) Stock Price Today?

The SCI Pharmtech stock price today is 85.70.

What Stock Exchange Does SCI Pharmtech Trade On?

SCI Pharmtech is listed and trades on the Taiwan stock exchange.

What Is the Stock Symbol for SCI Pharmtech?

The stock symbol for SCI Pharmtech is "4119."

Does SCI Pharmtech Pay Dividends? What’s The Current Dividend Yield?

The SCI Pharmtech dividend yield is 1.46%.

What Is the SCI Pharmtech Market Cap?

As of today, SCI Pharmtech market cap is 10.24B.

What is SCI Pharmtech Earnings Per Share?

The SCI Pharmtech EPS is 4.09.

What Is the Next SCI Pharmtech Earnings Date?

SCI Pharmtech will release its next earnings report on 13 Mar 2025.

From a Technical Analysis Perspective, Is 4119 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.